The Development Course of Chengdu Huashen Group Co., Ltd.

□1994 In April, Huashen Pharmaceutical Factory of Chengdu College of Traditional Chinese Medicine was established. At the beginning of its establishment, it leased the pharmaceutical factory affiliated to Chengdu College of Traditional Chinese Medicine for drug production. 1995, the company has achieved great success in the large-scale development of the pharmaceutical industry, and many products have great market development prospects. In order to create better economic and social benefits, the company invested 35 million yuan to build a new pharmaceutical production base. 1999, the new factory of Shuangliu Airport was completed and put into operation. The new factory is built in strict accordance with the national GMP standards, and the processing capacity of raw materials and oral liquid reaches 3000 tons. 1998 huashen pharmaceutical co., ltd., Chengdu university of traditional Chinese medicine, a secondary company of huashen group, was established. The company makes full use of the technical and resource advantages of pharmaceutical development, mainly engaged in pharmaceutical research, development, production and management. 1999 In May, Huashen Pharmaceutical Factory of Chengdu College of Traditional Chinese Medicine became a subsidiary of Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine and was renamed Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine; In September, 200 1 year, it was renamed as Chengdu Huashen Group Co., Ltd. Pharmaceutical Factory.

□1June, 1994, Biyuanshu oral liquid was listed as the second-class protected variety of Chinese medicine.

□ 1995, Biyuanshu oral liquid, the fist product of Chengdu Huashen Group Co., Ltd., won the gold medal of WHO World Congress of Traditional Medicine.

□ 1996, Biyuanshu oral liquid was listed as a new product in the Ninth Five-Year Plan and included in the National Spark Plan.

□/kloc-0. In July, 1996, Biyuanshu Capsule obtained the new drug certificate.

□ 1997, Huashen Group invested more than 35 million yuan to build a new pharmaceutical production base according to the national GMP standards, which was listed as a national key double-plus project by the state.

□199765438+February, Biyuanshu Capsule was jointly recognized as a national key new product by the State Science and Technology Commission, State Taxation Administration of The People's Republic of China, Ministry of Foreign Trade and Economic Cooperation, State Bureau of Technical Supervision and State Environmental Protection Bureau.

□1July 8, 1998, smokeless moxibustion strips were listed as the second-class protected varieties of Chinese medicine.

□1On July 8, 1998, Ergan Tuirening Oral Liquid was listed as the second-class protected variety of Chinese medicine.

□1On July 8, 1998, Tongjing Oral Liquid was listed as the second-class protected variety of Chinese traditional medicine.

□1On July 8th, 1998, Huolisu oral liquid was listed as the second-class protected variety of Chinese traditional medicine.

□ 1999 The pharmaceutical production base of Chengdu Huashen Group Co., Ltd. was completed and put into use.

□ On March 8th, 2000, Roxithromycin Granules obtained the new drug certificate.

□ In May 2000, granisetron hydrochloride Capsule obtained the new drug certificate.

□ From August 65438 to May 2000, the pharmaceutical factory of Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine was recognized by Sichuan Drug Administration as an A-level organization for quality management of pharmaceutical manufacturing enterprises.

On June 27th, 2000, 10, the capsules, tablets, granules and mixtures of Chengdu Huashen Group Co., Ltd. passed the national GMP certification at one time.

□ 2001May 27th, roxithromycin dispersible tablets obtained the new drug certificate.

□ On June 7th, 20065438+0, Biyuanshu oral liquid was listed as the second-class protected variety of Chinese traditional medicine.

□ In March 2002, anti-hepatic fibrosis traditional Chinese medicine and targeted preparation won the key innovation project of the State Economic and Trade Commission.

□ On June, 2003 12, Notoginseng Shu Tong Capsule and Notoginseng Triethanol Saponins obtained new drug certificates.

□ On June 23rd, 2003, 65438+February 23rd, 2003, the bulk drug (Panax notoginseng saponins) passed the national GMP certification.

□ In 2004, Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine passed the national GSP certification.

□ June, 5438+October, 2004 10, the pharmaceutical factory of Chengdu Huashen Group Co., Ltd. listed the research on the new drug (freeze-drying) of Panax notoginseng for injection as a key scientific and technological research project in Sichuan Province.

□ In April 2004, this Bromarone API and this Bromarone Capsule obtained the new drug certificate.

On August 13, 2004, Biyuanshu Capsule was listed as the second-class protected variety of traditional Chinese medicine.

□ In 2004, Sanqi Shu Tong Capsule was rated as a national new product.

□ June 5438+October 2004 10, Sanqi Shu Tong Capsule won the Excellent Product Award of the 6th China International Hi-tech Fair.

□ In March, 2005, the related research of Biyuanshu Oral Liquid (the research of Biyuanshu Oral Liquid on the fibrotic system of sinusitis in rats and its gene regulation) won the third prize of scientific and technological progress in Chengdu.

□ From June 5438 to February 65438 to March 2005, Huolisu oral liquid and Tongjing oral liquid were listed as the second-class protected varieties of Chinese traditional medicine.

□ On August 1 day, 2005, Ergan Tuirening Oral Liquid was listed as the second-class protected variety of Chinese medicine.

□ In May 2006, Rukang Granule obtained the certificate of new drug.

□ In June, 2006, 165438+ 10, the cooperation project between the company and the Department of Neurology, West China Hospital, "Study on the internationalization of drug registration cooperation of Sanqi Shu Tong Capsule (EU)" was listed as the "Eleventh Five-Year National Science and Technology Support Plan" and included in the public relations project of Chengdu Science and Technology Bureau.

□ June 5438+October 2007 10, the pharmaceutical factory of Chengdu Huashen Group Co., Ltd. passed the GMP certification for powder injection (cephalosporins).

□ In August, 2007, the pharmaceutical factory of Chengdu Huashen Group Co., Ltd. passed the GMP certification of raw materials (Gentiana scabra extract).

□ In May, 2007, the pharmaceutical factory of Chengdu Huashen Group Co., Ltd. "Process Optimization and Industrialization Transformation of Purification of Panax Notoginseng Saponins with Macroporous Adsorption Resin" was included in the National Torch Plan.

□ June 5438+October 2007 10, Chengdu University of Traditional Chinese Medicine Huashen Pharmaceutical Co., Ltd. was recognized as a high-tech enterprise.

□ June, 5438+October, 2008/kloc-0, Chengdu Huashen Group Co., Ltd. won the third prize of scientific and technological progress in Shuangliu County.

□ On September, 2008 12, Cefepime Hydrochloride obtained the new drug certificate.

□ In September 2008, the craft of Biyuanshu variety "A Chinese medicinal composition and its preparation method" was authorized by the national invention patent, which won the exclusive right of this variety for about 20 years for Chinese ginseng.

□ In September, 2008, Chengdu Huashen Group Co., Ltd. Pharmaceutical Factory's "R&D platform construction pilot of modern Chinese medicine separation and purification integration technology" was included in the innovation capacity building project of National Development and Reform Commission Technology Center.

□ June, 5438+October, 2008/KLOC-0, "Research and Development of Panax Notoginseng Triethanol Saponin and Its Preparation Panax Notoginseng Shu Tong Capsule" won the third prize of China Pharmaceutical Association for Scientific and Technological Progress.

□ On February 25th, 2008, at 65438, Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine passed the national high-tech enterprise certification again.

□ June 5438+February 2008, Sanqi Shu Tong Capsule won the title of "High-tech Innovative Product" in Sichuan Province.

□ On June 26, 2008, February 26, 5438, cefpirome sulfate obtained the new drug certificate.

□ In March 2009, Huashen Pharmaceutical Co., Ltd. of Chengdu University of Traditional Chinese Medicine passed GSP re-certification; Sanqi Tongshu Capsule won the honor of high-tech innovative products and key new products in Sichuan Province.

□ From April to June, 2009, the "Wulong Granule", "Shubi Lotion" and "Sanqi Tongbi Capsule" independently developed by Chengdu Huashen Group Co., Ltd. won the national invention patent authorization certificate.

□ In May 2009, the moxibustion workshop of Chengdu Huashen Group Co., Ltd. passed GMP certification; Biyuanshu Oral Liquid, Biyuanshu Capsule, Sanqitongshu Capsule, Huolisu Oral Liquid, Yiqing Granule, Radix Gentianae Extract Tablet, Ergan Tuirening Oral Liquid and Smokeless Moxibustion Bar are listed as the recommended catalogue of local famous products.

□ In September, 2009, Compound Danshen Tablets and Jiuwei Notopterygium Granules entered the national list of essential drugs (2009 edition).

□ From June 5438 to February 2009, the quality standards of five varieties of Huolisu Oral Liquid, Ergan Tuirening Oral Liquid, Panax Notoginseng Saponins, Biyuanshu Capsule and Smokeless Moxibustion Bar were successfully included in China Pharmacopoeia.

□2065 438+00 On June 25th and 26th, Chengdu Huashen Group Co., Ltd. passed GMP re-certification.

□ 2065438+July 2000, the pharmaceutical factory of Chengdu Huashen Group Co., Ltd. located in Guixi Township, Beichuan County, Sichuan Province, covering an area of 700 hectares, was approved by the Sichuan Provincial Department of Agriculture and was recognized as the origin of pollution-free agricultural products in Sichuan Province.